Literature DB >> 7013675

Prostaglandins and the ductus arteriosus.

P M Olley, F Coceani.   

Abstract

Fetal patency of the ductus arteriosus is an active state maintained by the relaxant action of a prostaglandin, most probably prostaglandin E2. This PG mechanism is most active in the immature ductus and decreases toward term. The ductus closes when this prostaglandin effect if withdrawn. Indomethacin may induce closure of the patent ductus arteriosus of prematurity. It is most likely to be successful if given intravenously and early in postnatal life. Prostaglandin E1, to maintain patency of the ductus, is now established in the emergency management of several congenital heart defects causing problems in the newborn.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7013675     DOI: 10.1146/annurev.me.32.020181.002111

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  7 in total

1.  Prenatal constriction of the ductus arteriosus following maternal diclofenac medication in the third trimester.

Authors:  Karoline Aker; Anne Brantberg; Siri Ann Nyrnes
Journal:  BMJ Case Rep       Date:  2015-10-01

Review 2.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

3.  Changes of clinical, electrolytes, acute phase proteins, and some cardiovascular biomarkers in lambs and kids from birth to 2 days of age.

Authors:  Amir Saeed Samimi
Journal:  Trop Anim Health Prod       Date:  2019-02-19       Impact factor: 1.559

4.  Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.

Authors:  R Mrongovius; H Imbeck; L Wille; H Müller; H W Seyberth
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

5.  Role of dynamin-related protein 1 (Drp1)-mediated mitochondrial fission in oxygen sensing and constriction of the ductus arteriosus.

Authors:  Zhigang Hong; Shelby Kutty; Peter T Toth; Glenn Marsboom; James M Hammel; Carolyn Chamberlain; John J Ryan; Hannah J Zhang; Willard W Sharp; Erik Morrow; Kalyani Trivedi; E Kenneth Weir; Stephen L Archer
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

6.  Prostaglandin E1 responsive ductus at 11 months of age.

Authors:  I A Kashani; G A Schmunk; T A Merritt; R E Swensson; J R Utley
Journal:  Pediatr Cardiol       Date:  1984 Jan-Mar       Impact factor: 1.655

7.  Association between Furosemide Exposure and Patent Ductus Arteriosus in Hospitalized Infants of Very Low Birth Weight.

Authors:  Elizabeth J Thompson; Rachel G Greenberg; Karan Kumar; Matthew Laughon; P Brian Smith; Reese H Clark; Andromeda Crowell; Layla Shaw; Louis Harrison; Gabrielle Scales; Nicole Bell; Christoph P Hornik
Journal:  J Pediatr       Date:  2018-05-08       Impact factor: 6.314

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.